<< Strategies to adopt for conducting clinical trials in emerging regions | Maximum Weight Limit is the new measure to calculate healthy weight >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | العربية | Nederlands | Русский | Svenska | Polski

Conference to focus on the impact of healthcare proposals on diagnostic testing

Published on September 19, 2009 at 4:11 AM · No Comments

Enzo Biochem, Inc. (NYSE:ENZ) announced today that Kevin Krenitsky, MD, President of Enzo Clinical Labs, will present at the 27th Annual Lab Institute ’09, sponsored by Washington G2 Reports, on September 23, 2009 in Arlington, Virginia.

Dr. Krenitsky will present at a panel discussion entitled “Going Inside the Boardroom: What’s the Bottom Line for Labs During a Time of Economic, Policy and Market Flux?”

Among the meeting’s keynote speakers will be the Hon. Newt Gingrich, former Speaker of the U.S. House of Representatives, and Rep. Pete Stark (D-CA), Chairman, House Ways and Means Health Subcommittee.

“The focus of this key conference, which comes at a pivotal time in the debate over health care reform, will be on the impact various proposals will have on diagnostic testing, which, given all the advances being made in diagnosing diseases and how treatments are gauged, will figure importantly in the way medicine is practiced and patients treated in the future,” said Dr. Krenitsky. “It is a welcome opportunity that a leading independent laboratory such as Enzo Clinical Labs has been invited to be part of this dialogue.”

www.enzo.com

Posted in: Device / Technology News

Tags: , , , , ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading